168 related articles for article (PubMed ID: 7832277)
1. Immunostaining in the diagnosis of pulmonary neuroendocrine carcinomas. An immunohistochemical study with ultrastructural correlations.
Loy TS; Darkow GV; Quesenberry JT
Am J Surg Pathol; 1995 Feb; 19(2):173-82. PubMed ID: 7832277
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder.
Bollito ER; Pacchioni D; Lopez-Beltran A; Volante M; Terrone C; Casetta G; Mari M; DePompa R; Cappia S; Papotti M
Anal Quant Cytol Histol; 2005 Aug; 27(4):218-24. PubMed ID: 16220833
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
Lyda MH; Weiss LM
Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
[TBL] [Abstract][Full Text] [Related]
4. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
Kasprzak A; Zabel M; Biczysko W
Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
[TBL] [Abstract][Full Text] [Related]
5. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
[TBL] [Abstract][Full Text] [Related]
6. Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance.
Ionescu DN; Treaba D; Gilks CB; Leung S; Renouf D; Laskin J; Wood-Baker R; Gown AM
Am J Surg Pathol; 2007 Jan; 31(1):26-32. PubMed ID: 17197916
[TBL] [Abstract][Full Text] [Related]
7. Results after surgery in undifferentiated large cell carcinoma of the lung: the role of neuroendocrine expression.
Wertzel H; Grahmann PR; Bansbach S; Lange W; Hasse J; Böhm N
Eur J Cardiothorac Surg; 1997 Nov; 12(5):698-702. PubMed ID: 9458138
[TBL] [Abstract][Full Text] [Related]
8. INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity.
Rooper LM; Sharma R; Li QK; Illei PB; Westra WH
Am J Surg Pathol; 2017 Nov; 41(11):1561-1569. PubMed ID: 28719469
[TBL] [Abstract][Full Text] [Related]
9. The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study.
Kiriakogiani-Psaropoulou P; Malamou-Mitsi V; Martinopoulou U; Legaki S; Tamvakis N; Vrettou E; Fountzilas G; Skarlos D; Kosmidis P; Pavlidis N
Lung Cancer; 1994 Dec; 11(5-6):353-64. PubMed ID: 7535640
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine differentiation in non-small cell lung carcinomas.
Baldi A; Groger AM; Esposito V; Di Marino MP; Ferrara N; Baldi F
In Vivo; 2000; 14(1):109-14. PubMed ID: 10757067
[TBL] [Abstract][Full Text] [Related]
12. Gastrin-releasing peptide gene expression in small cell and large cell undifferentiated lung carcinomas.
Sunday ME; Choi N; Spindel ER; Chin WW; Mark EJ
Hum Pathol; 1991 Oct; 22(10):1030-9. PubMed ID: 1668786
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical localization of neuron specific enolase in small cell carcinomas and carcinoid tumours of the lung.
Sheppard MN; Corrin B; Bennett MH; Marangos PJ; Bloom SR; Polak JM
Histopathology; 1984 Mar; 8(2):171-81. PubMed ID: 6202617
[TBL] [Abstract][Full Text] [Related]
14. Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections.
Mukhopadhyay S; Dermawan JK; Lanigan CP; Farver CF
Mod Pathol; 2019 Jan; 32(1):100-109. PubMed ID: 30154579
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK
Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine differentiation in colorectal carcinomas: assessing its prognostic significance.
Atasoy P; Ensari A; Demirci S; Kurşun N
Tumori; 2003; 89(1):49-53. PubMed ID: 12729362
[TBL] [Abstract][Full Text] [Related]
17. Reliability of commercially available immunocytochemical markers for identification of neuroendocrine differentiation in bronchoscopic biopsies of bronchial carcinoma.
Gosney JR; Gosney MA; Lye M; Butt SA
Thorax; 1995 Feb; 50(2):116-20. PubMed ID: 7701447
[TBL] [Abstract][Full Text] [Related]
18. Large cell carcinoma of the lung with neuroendocrine differentiation. A comparison with large cell "undifferentiated" pulmonary tumors.
Wick MR; Berg LC; Hertz MI
Am J Clin Pathol; 1992 Jun; 97(6):796-805. PubMed ID: 1317668
[TBL] [Abstract][Full Text] [Related]
19. Chromogranin A gene expression in non-small cell lung carcinomas.
Abbona G; Papotti M; Viberti L; Macrĭ L; Stella A; Bussolati G
J Pathol; 1998 Oct; 186(2):151-6. PubMed ID: 9924430
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]